Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer.

Home
Find People
Find Everything
About This Site
Annual Report
Export RDF

Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer.

Leeder JS. Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer. Clin Pharmacol Ther. 2015 Feb; 97(2):119-21.

View in: PubMed

subject areas

Cytochrome P-450 Enzyme System
Genetic Testing
Humans
Pharmacogenetics

authors with profiles

J. Steven Leeder